Skip to main content
Perhaps you meant penitentiary standards?

Search results for "evidentiary standards"

Filters: Medical Technologies and Treatments Medical Technologies and Treatments ×
Viewing 1 - 17 of 17 results by relevance
Consensus Study Report

Biomarker Tests for Molecularly Targeted Therapies: Key to Unlocking Precision Medicine  (2016)

Proceedings

Genome-Based Diagnostics: Clarifying Pathways to Clinical Use: Workshop Summary  (2012)

Proceedings

Advancing the Discipline of Regulatory Science for Medical Product Development: An Update on Progress and a Forward-Looking Agenda: Workshop Summary  (2016)

Proceedings

Accelerating the Development of Biomarkers for Drug Safety: Workshop Summary  (2009)

Proceedings

Generating Evidence for Genomic Diagnostic Test Development: Workshop Summary  (2011)

Perspectives on Biomarker and Surrogate Endpoint Evaluation: Discussion Forum Summary  (2011)

Consensus Study Report

Evaluation of Biomarkers and Surrogate Endpoints in Chronic Disease  (2010)

Proceedings

Extending the Spectrum of Precompetitive Collaboration in Oncology Research: Workshop Summary  (2010)

Proceedings

The Economics of Genomic Medicine: Workshop Summary  (2013)

Proceedings

International Regulatory Harmonization Amid Globalization of Drug Development: Workshop Summary  (2013)

Proceedings

Genome-Based Therapeutics: Targeted Drug Discovery and Development: Workshop Summary  (2012)

Consensus Study Report

Medical Devices and the Public's Health: The FDA 510(k) Clearance Process at 35 Years  (2011)

Consensus Study Report

Ethical and Scientific Issues in Studying the Safety of Approved Drugs  (2012)

Proceedings

Developing Multimodal Therapies for Brain Disorders: Proceedings of a Workshop  (2017)

Proceedings

Policy Issues in the Development and Adoption of Biomarkers for Molecularly Targeted Cancer Therapies: Workshop Summary  (2015)

Proceedings

Examining the Impact of Real-World Evidence on Medical Product Development: Proceedings of a Workshop Series  (2019)

Proceedings

Envisioning a Transformed Clinical Trials Enterprise in the United States: Establishing an Agenda for 2020: Workshop Summary  (2012)